Yüklüyor......
Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature
Bevacizumab, an angiogenesis inhibitor, is a recombined humanized monoclonal antibody against vascular endothelial growth factor and a promising therapeutic option for angiosarcoma management. This is a case report and review of the literature using bevacizumab and combination chemotherapy for angio...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3696716/ https://ncbi.nlm.nih.gov/pubmed/23825914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2013.06.09 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|